1. Ambler, RP. The structure of β-lactamases. Phil. Trans. R Soc. Lond. B, London, v. 289, n. 1036, pp. 321-31, May 1980.
2. Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997–2001). J. Antimicrob. Chemother., London, v. 52, n. 1, pp.140-1, jul. 2003.
3. CLSI (Clinical and Laboratory Standards Institute). Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement – Table M100 – S18, Wayne, PA: NCCLS, 2009.
4. Sequence analysis of ARI-1, a novel OXA β-Lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob;Donald;Agents Chemother London, oct,2003
5. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase;Gales;J. Antimicrob. Chemother., London,2003